Literature DB >> 117384

An IgG primary sequence exposure theory for complement activation using synthetic peptides.

R J Boackle, B J Johnson, G B Caughman.   

Abstract

Mesh:

Substances:

Year:  1979        PMID: 117384     DOI: 10.1038/282742a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Nomenclature for synthetic peptides representative of immunoglobulin chain sequences. WHO-IUIS Nomenclature Sub-Committee.

Authors: 
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment.

Authors:  Hee Young Hwang; Marcus R Duvall; Stephen Tomlinson; Robert J Boackle
Journal:  Mol Immunol       Date:  2008-03-03       Impact factor: 4.407

3.  Comparison of the role of tyrosine residues in human IgG and rabbit IgG in binding of complement subcomponent C1q.

Authors:  M N McCall; S B Easterbrook-Smith
Journal:  Biochem J       Date:  1989-02-01       Impact factor: 3.857

4.  Linkage and sequence homology of two human immunoglobulin gamma heavy chain constant region genes.

Authors:  J Ellison; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1982-03       Impact factor: 11.205

5.  Formation of complement subcomponent C1q-immunoglobulin G complex. Thermodynamic and chemical-modification studies.

Authors:  E J Emanuel; A D Brampton; D R Burton; R A Dwek
Journal:  Biochem J       Date:  1982-08-01       Impact factor: 3.857

6.  Complement activation by whole endotoxin is blocked by a monoclonal antibody to factor B.

Authors:  C W Clardy
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

Review 7.  The first component of human complement (C1): activation and control.

Authors:  R J Ziccardi
Journal:  Springer Semin Immunopathol       Date:  1983
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.